21 May 2009
Myocardial blush grade (mbg) is not altered by microvasculopathy or acute rejection (ar) occurring early after orthotopic heart transplantation (OHT)
M Zakliczyński, A Lekston, D Konecka-Mrówka, J Nożyński, D Trybunia, Ł Pyka, M Świerad, R Przybylski, M ZembalaAnn Transplant 2009; 14(1): 65-65 :: ID: 880438
Abstract
Background: A relation between microvasculopathy observed in endomyocardial biopsies (EMBs) and clinical coronary vasculopathy (CAV) after OHT remains controversial. Aim of the study was to find a potential relation between microvasculopathy features and AR observed early after OHT and MBG.
Material/Methods: We performed a retrospective analysis of early coronary
angiographies (performed between 4th and 6th week after OHT) from 55 subjects. Based on MBG analysis we identifi ed a group of six pts. with decreased MBG (6M, 52±7y/o, ischemic c-pathy in 50%), that was confronted with a group of 49 pts. with normal MBG (43M/6F, 45±12y/o, ischemic c-pathy in 39%). Microvasculopathy was assessed using the following features: presence of prominent endothelial cells, degeneration of the endothelium, thickening of the muscle layer, thickening of the vascular wall (basal membrane and muscle layer), presence of lymphocytes in the arteriolar wall with-out any other signs of rejection vasculitis, periarteriolar fibrosis, and an occluded arteriolar lumen.
Results: Significant AR was observed in 17 vs. 10% of pts. with decreased and normal MBG, respectively. All microvasculopathy features, except presence of prominent endothelial cells and periarteriolar fibrosis, were more frequent in pts. with normal MBG. None of the differences was statistically significant.
Conclusions: MBG is not influenced by AR or microvasculopathy features observed early after OHT.
Keywords: Heart Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






